TrialThe lancet. Gastroenterology & hepatology2026

Dupilumab versus placebo in adults and adolescents with eosinophilic gastritis (DEGAS): a double-blind, placebo-controlled, phase 2, multicentre, randomised controlled trial.

Nirmala P Gonsalves et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.